CompletedPhase 4NCT02084576
Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospital Oftalmologico de Brasilia
- Principal Investigator
- Patrick F Tzelikis, MD, PhDHospital Oftalmologico de Brasilia
- Intervention
- Nepafenac(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 40-80 years · All sexes
- Timeline
- 2013 – 2014
Study locations (1)
- Hospital Oftalmologico de Brasília, Brasília, Federal District, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02084576 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.